Rusan Pharma

Rusan Pharma achieves key GMP approvals for Australian and Brazilian markets

Read more

Rusan Pharma launches ‘No Reason is Good Enough’ to promote tobacco de-addiction

Read more

NSRT to start Phase II trial of Eflornithine granules to treat COVID-19 by early Jan 2021

Read more

Rusan Pharma launches R&D centre at Kandla SEZ

Read more

Rusan Pharma launches first ‘Made in India’ NRT patch 2baconil

Read more